As histone deacetylation plays an important role in the expression of many genes responsible for viral inclusions, several histone deacetylase inhibitors have been reported to downregulate ACE2 expression, making it a potential modulator of COVID-19 and related CS. The gene discussed is ACE2; the disease is Cowden syndrome 1.